Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yili Group, officially Inner Mongolia Yili Industrial Group Co., Ltd., is the largest dairy producer in Asia and a global leader in the health food and nutrition industry. Headquartered in Hohhot, China, the company has expanded its focus beyond traditional dairy into advanced life sciences, particularly in the fields of probiotics, human milk research, and functional nutrition. Yili operates a robust global R&D network, including the Yili Innovation Center Europe in the Netherlands, which collaborates with Wageningen University on food science and health. The company's product portfolio features liquid milk, infant formula, and yogurt, often incorporating proprietary bioactive ingredients such as the probiotic strain Bifidobacterium animalis BL-99. As a publicly traded entity on the Shanghai Stock Exchange, Yili continues to invest in smart dairy technologies and sustainable manufacturing to address global health and wellness trends. Its strategic acquisitions, such as Westland Milk Products and Ausnutria Dairy, have further solidified its position in the specialized nutrition and healthcare-adjacent markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yili Group.